Verastem Oncology Competitors and Similar CompaniesClear all
Novartis's competitors and similar companies include Relay Therapeutics and Mirati Therapeutics.
 Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. |  Relay Therapeutics Relay Therapeutics was founded on the premise that putting protein motion at the heart of drug discovery can dramatically expand therapeutic possibilities. |  Mirati Therapeutics Mirati Therapeutics is an oncology company that designs and develops targeted therapies to address the genetic drivers of cancer. | |
Founding Date | Founding Date 1996 | Founding Date 2016 | Founding Date 2013 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations Cambridge, US HQ | Locations San Diego, US HQ Zug, CH |
Employees | Employees 75,883 | Employees 2724% decrease | Employees 666% decrease |
Financial | |||
Revenue (est.) | Revenue (est.) $56.7b (FY, 2025) | Revenue (est.) $15.4m (FY, 2025) | Revenue (est.) $12.4m (FY, 2022) |
Cost of goods | Cost of goods $8.4b (FY, 2025) | Cost of goods N/A | Cost of goods $600k (FY, 2022) |
Gross profit | Gross profit $49.8b (FY, 2025) | Gross profit N/A | Gross profit $11.8m (FY, 2022) |
Net income | Net income $14b (FY, 2025) | Net income ($276.5m) (FY, 2025) | Net income ($740.9m) (FY, 2022) |
Funding | |||
Total funding raised | Total funding raised $ 6.5m | Total funding raised $ 520m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Relay Therapeutics
HQ
Cambridge, US
Employees
272↓ 4% decrease
Relay Therapeutics was founded on the premise that putting protein motion at the heart of drug discovery can dramatically expand therapeutic possibilities.
View companyMirati Therapeutics
HQ
San Diego, US
Mirati Therapeutics is an oncology company that designs and develops targeted therapies to address the genetic drivers of cancer.
View company